tiprankstipranks
Trending News
More News >
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
US Market
Advertisement

Gyre Therapeutics (GYRE) Technical Analysis

Compare
817 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Gyre Therapeutics’s (GYRE) Moving Averages Convergence Divergence (MACD) indicator is 0.05, suggesting Gyre Therapeutics is a Sell.
Gyre Therapeutics’s (GYRE) 20-Day exponential moving average is 7.57, while Gyre Therapeutics’s (GYRE) share price is $7.55, making it a Sell.
Gyre Therapeutics’s (GYRE) 50-Day exponential moving average is 7.79, while Gyre Therapeutics’s (GYRE) share price is $7.55, making it a Sell.

Gyre Therapeutics (GYRE) Pivot Points

Aug 23, 2025, 12:49 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.07
7.21
7.47
7.61
7.87
8.01
8.27
Fibonacci
7.21
7.36
7.46
7.61
7.76
7.86
8.01
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Gyre Therapeutics (GYRE) Moving Averages

Aug 23, 2025, 12:49 PM
Period
Simple
Exponential
MA5
7.76Sell
7.69Sell
MA10
7.70Sell
7.65Sell
MA20
7.45Buy
7.57Sell
MA50
7.59Sell
7.79Sell
MA100
8.26Sell
8.46Sell
MA200
9.92Sell
9.88Sell
Gyre Therapeutics’s (GYRE) 10-Day exponential moving average is 7.65, while Gyre Therapeutics’s (GYRE) share price is $7.55, making it a Sell.
Gyre Therapeutics’s (GYRE) 100-Day exponential moving average is 8.46, while Gyre Therapeutics’s (GYRE) share price is $7.55, making it a Sell.
Gyre Therapeutics’s (GYRE) stock price is $7.55 and Gyre Therapeutics’s (GYRE) 50-day simple moving average is 7.59, creating a Sell signal.
Gyre Therapeutics’s (GYRE) stock price is $7.55 and Gyre Therapeutics’s (GYRE) 100-day simple moving average is 8.26, creating a Sell signal.
Gyre Therapeutics’s (GYRE) stock price is $7.55 and Gyre Therapeutics’s (GYRE) 200-day simple moving average is 9.92, creating a Sell signal.

Gyre Therapeutics (GYRE) Technical Indicators

Aug 23, 2025, 12:49 PM
Name
Value
Implied Action
RSI (14)
49.53
Neutral
STOCH (9,6)
58.53
Neutral
STOCHRSI (14)
59.30
Neutral
MACD (12,26)
0.05
Sell
ADX (14)
17.42
Buy
Williams %R
-44.64
Buy
CCI (14)
31.81
Neutral
ATR (14)
0.44
-
Ultimate Oscillator
61.39
Neutral
ROC
13.53
Buy
Gyre Therapeutics’s (GYRE) Relative Strength Index (RSI) is 49.53, creating a Neutral signal.
Gyre Therapeutics’s (GYRE) Trend Strength Indicator (ADX) is 17.42, creating a Buy signal.
Gyre Therapeutics’s (GYRE) Commodity Channel Index (CCI) is 31.81, creating a Neutral signal.
Gyre Therapeutics’s (GYRE) Price Rate of Change (ROC) is 13.53, creating a Buy signal.

FAQ

Is GYRE a Buy, Hold, or Sell?
Based on GYRE’s technical indicators, GYRE is a Sell.
    What is GYRE’s RSI (14)?
    GYRE’s RSI (14) is 49.53, which suggests GYRE is a Neutral.
      What is GYRE’s MACD?
      GYRE’s MACD is 0.05, which suggests GYRE is a Sell.
        What is GYRE’s 5-day moving average?
        GYRE’s 5-day moving average is 7.76, which suggests GYRE is a Sell.
          What is GYRE’s 20-day moving average?
          GYRE 20-day moving average is 7.45, which suggests GYRE is a Buy.
            What is GYRE’s 50-day moving average?
            GYRE’s 50-day moving average is 7.59, which suggests GYRE is a Sell.
              What is GYRE’s 200-day moving average?
              GYRE’s 200-day moving average is 9.92, which suggests GYRE is a Sell.
                What is GYRE’s Williams % R (14)?
                GYRE’s Williams % R (14) is -44.64, which suggests GYRE is a Buy.
                  What is GYRE’s CCI (14)?
                  GYRE’s CCI (14) is 31.81, which suggests GYRE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis